The New Normal Fund
VC · San Francisco · United States
Stages
Investment region
Industries
Profile
The New Normal Fund is a venture capital firm based in San Francisco, California, founded by Allison Pickens, a former COO at Gainsight. As a solo GP investor, Allison leverages her extensive experience in B2B AI and SaaS to support founders as a thought partner on go-to-market strategies and scaling businesses. The firm is known for its unique approach of partnering with B2B AI founders, offering board-level strategic guidance without taking a board seat, and is backed by a network of over 20 CEOs and operators. The New Normal Fund primarily invests in AI startups, focusing on sectors such as SaaS, enterprise, and data infrastructure. The firm typically writes checks ranging from $400K to $1M for seed-stage investments and occasionally $250-500K for Series A rounds through its opportunity fund. The fund has a strong presence in the USA and has been involved in notable investments in companies like Gamma, Tennr, Modal, EvenUp, Norm Ai, dbt Labs, Hightouch, and Scribe. Notable portfolio companies include Gamma - AI platform, Tennr - data infrastructure, Modal - SaaS solutions, EvenUp - AI applications, and Norm Ai - enterprise tech. The firm has also invested in dbt Labs, Hightouch, and Scribe, showcasing its commitment to supporting innovative AI and data-driven startups.
Contatos (1)
| Name | Title | Telefone | ||
|---|---|---|---|---|
| — | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.